Our analysis revealed that, unlike HER2 positive, Luminal A, Luminal B, or normal-like cancer types, many of the basal subtype breast cancer samples consistently displayed simultaneous up- and down- regulation of GLS and GLUL gene expression, respectively (Fig 1A). The gene discussed is GLS; the disease is breast cancer.